Technological support to intensive insulin therapy by a novel smartphone application in young adults with type 1 diabetes: one center's experience
In our Diabetes Centre at Sapienza University of Rome, Italy, we have been exploring the potential benefits of using technology in diabetes care, with a particular focus on T1DM patients receiving flexible intensive insulin therapy (MDI), who do not take advantage of automatic bolus calcu- lators as do those treated with insulin pumps. Therefore, from its launch in 2016, we have been suggesting the mobile app RapidCalc1 to T1DM subjects using MDI, and with knowledge and experience in technology.